Zeal leads pre-seed and seed rounds and participates at Series A. Our directory lists Pre-Seed, Seed, and Series A coverage; Fund II targets roughly 25 early-stage companies.

Our 2026 coverage cites $1–2.3M seed checks with ~50% of Fund II reserved for follow-ons. Zeal's Fund II closed at $82M in May 2025.

Zeal has offices in New York and Washington D.C. The firm invests in U.S. companies aligned with its inclusive fintech, healthcare, and future-of-work thesis — geography follows mission-fit founders rather than a single-city mandate.

Zeal practices 'Inclusive Investing' in fintech, healthcare, and the future of learning and work — backing underrepresented founders building wealth, health, and skills infrastructure. Our directory tags fintech. Notable portfolio company Esusu reached unicorn status.

Zeal routinely leads or co-leads seed rounds — our coverage notes Zeal led Rising Team's $8M Series A and backed Seven Starling's $8M round in 2025.

No startups in our directory currently list Zeal Capital Partners as an investor. Portfolio companies including Esusu are on zealcapital.com; we will link directory entries when investor relationships are publicly evidenced.

Review zealcapital.com for thesis alignment (fintech, healthcare, future of work). Warm introductions from portfolio founders, impact investors, or D.C./NYC ecosystem operators are standard. Zeal does not promote a public cold-pitch email.

See 2026-zeal-capital-partners-82m-fund-ii for the $82M Fund II close ($186M total AUM) and 2026-zeal-capital-partners-rising-team-seven-starling for early Fund II deployments.